chr5-112840326-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. BS3_SupportingBP1PS4
This summary comes from the ClinGen Evidence Repository: The c.4732T>G variant in APC is a missense variant predicted to cause the substitution of cysteine by glycine at amino acid position 1578 (p.Cys1578Gly). This variant has been reported in 21 families with FAP worth 9 phenotype points (PS4, Ambry, GeneDX and Invitae internal data). The highest population minor allele frequency in the non-cancer cohort of gnomAD v2.1.1 is 0.0009780% in the non-Finnish European population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel’s (HCCP VCEP) threshold ≤ 0.0008% for PM2_Supporting (PM2_Supporting not met). A luciferase reporter plasmid transiently transfected into SW480 cells is able to suppress beta-catenin-regulated transcription indicating that this variant does not impact protein function (BS3_Supporting; PMID 18199528). APC is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). Due to conflicting evidence, this variant is classified as a Variant of Uncertain Significance (VUS) for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: PS4, BS3_Supporting, BP1 (VCEP specifications version 1; date of approval: 12/12/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA009712/MONDO:0021056/089
Frequency
Consequence
NM_000038.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APC | NM_000038.6 | c.4732T>G | p.Cys1578Gly | missense_variant | 16/16 | ENST00000257430.9 | NP_000029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.4732T>G | p.Cys1578Gly | missense_variant | 16/16 | 5 | NM_000038.6 | ENSP00000257430.4 | ||
ENSG00000258864 | ENST00000520401.1 | n.228+11354T>G | intron_variant | 3 | ENSP00000454861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250924Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135672
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461880Hom.: 0 Cov.: 66 AF XY: 0.00000138 AC XY: 1AN XY: 727242
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:1Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change replaces cysteine, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 1578 of the APC protein (p.Cys1578Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of familial adenomatous polyposis (PMID: 18199528; Invitae). ClinVar contains an entry for this variant (Variation ID: 140839). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on APC function (PMID: 18199528). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, reviewed by expert panel | curation | ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel | Feb 26, 2023 | The c.4732T>G variant in APC is a missense variant predicted to cause the substitution of cysteine by glycine at amino acid position 1578 (p.Cys1578Gly). This variant has been reported in 21 families with FAP worth 9 phenotype points (PS4, Ambry, GeneDX and Invitae internal data). The highest population minor allele frequency in the non-cancer cohort of gnomAD v2.1.1 is 0.0009780% in the non-Finnish European population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel’s (HCCP VCEP) threshold (0.0008%) for PM2_Supporting (PM2_Supporting not met). A luciferase reporter plasmid transiently transfected into SW480 cells is able to suppress beta-catenin-regulated transcription indicating that this variant does not impact protein function (BS3_Supporting; PMID 18199528). APC is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). Due to conflicting evidence, this variant is classified as a Variant of Uncertain Significance (VUS) for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: PS4, BS3_Supporting, BP1 (VCEP specifications version 1; date of approval: 12/12/2022). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 31, 2023 | - - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 18, 2019 | The APC c.4732T>G; p.Cys1578Gly variant (rs138367627) is reported in the literature in an individual affected with multiple colorectal adenomas (Azzopardi 2008). This variant is found on a single chromosome (1/250924 alleles) in the Genome Aggregation Database, indicating it is not a common polymorphism. The cysteine at codon 1578 is highly conserved across species, located in the SAMP repeats/axin binding domain (Azzopardi 2008), and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, in functional assays, the p.Cys1578Gly variant suppressed beta-catenin-regulated transcription to the same extent as wildtype protein (Azzopardi 2008). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Azzopardi D et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res. 2008 Jan 15;68(2):358-63. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 21, 2019 | Variant summary: APC c.4732T>G (p.Cys1578Gly) results in a non-conservative amino acid change located in the SAMP repeats/axin binding domain (Azzopardi 2008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Five predict the variant creates a cryptic 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-06 in 250924 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4732T>G has been reported in the literature in one individual affected with colorectal adenomas (Azzopard_2008). The report does not provide unequivocal conclusions about association of the variant with Familial Adenomatous Polyposis. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Azzopard_2008). Four ClinVar submitter (evaluation after 2014) cite the variant as likely pathogenic (2x) and uncertain significance (2x). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 05, 2024 | Published functional study demonstrates CRT suppression similar to wild type (PMID: 18199528); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21859464, 18199528, 24055113, 28152038, 25637381, 37542411) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The p.C1578G variant (also known as c.4732T>G), located in coding exon 15 of the APC gene, results from a T to G substitution at nucleotide position 4732. The cysteine at codon 1578 is replaced by glycine, an amino acid with highly dissimilar properties. This variant has been detected in multiple individuals with colorectal polyposis, and it is located in a conserved SAMP repeat that functions as an axin binding domain (Azzopardi et al. Cancer Res. 2008 Jan;68:358-63; Minde DP et al. Mol. Cancer. 2011 Aug;10:101; Spink KE et al. EMBO J. 2000 May;19:2270–9; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, in silico predictors for this gene do not accurately predict pathogenicity. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Classic or attenuated familial adenomatous polyposis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 11, 2024 | This missense variant replaces cysteine with glycine at codon 1578 of the APC protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown that this variant retained >80% of wild-type APC inhibitory activity on beta--Catenin as assessed by beta--Catenin-regulated transcription (CRT) assays (PMID: 18199528). This variant has been reported in individuals affected with familial adenomatous polyposis and colorectal adenoma (ClinVar: SCV000172947.9, SCV000260260.11, SCV000293423.12; PMID: 18199528). This variant has been identified in 1/250924 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Colorectal adenoma Uncertain:1
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at